Activation of autophagy by CP contributes to its chemoresistance in esophageal cancer (O’Donovan et al., 2011), ovarian cancer (Bao et al., 2015), bladder cancer (Lin et al., 2017), and osteosarcoma (Jiang et al., 2017). Here, CP is linked to ovarian carcinoma.